Why the Targeted Radionuclide Therapy Market Is Gaining Global Momentum
The increasing adoption of precision oncology is driving demand for targeted radionuclide therapies, but the market also faces several challenges. High treatment costs, limited availability of medical radioisotopes, complex manufacturing and distribution requirements, and stringent regulatory approvals can restrict market growth. In addition, the need for specialized nuclear medicine...
0 Comments 0 Shares 149 Views 0 Reviews